Ingredients: 100% Pure Citrulline Malate, Silicon Dioxide (2%)
Platelet-associated parameters included: platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV), and platelet distribution width (PDW)
Adenovirus-based therapies Gendicine, the first p53 gene therapy, is a recombinant human p53 adenovirus that was approved in 2003 by the China Food and Drug Administration (CFDA) for the treatment of HNSCC
Weekly dose Units per injection (mL) Syringe fill level Frequency: Once daily , commonly structured as 5 days per week with 2 rest days to support recovery cycles and consistent tracking
It also causes contraction of the iris sphincter muscle, which constricts the pupil, but maintains some pupillary response to light